Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Mallinckrodt
Merck
Johnson and Johnson
Colorcon

Last Updated: May 20, 2022

Neurocrine Company Profile


✉ Email this page to a colleague

« Back to Dashboard

Summary for Neurocrine
International Patents:243
US Patents:28
Tradenames:2
Ingredients:2
NDAs:2
Patent Litigation for Neurocrine: See patent lawsuits for Neurocrine

Drugs and US Patents for Neurocrine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-001 Apr 11, 2017 RX Yes No 10,851,104 See Plans and Pricing Y See Plans and Pricing
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-003 Apr 23, 2021 RX Yes No 10,993,941 See Plans and Pricing See Plans and Pricing
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-003 Apr 23, 2021 RX Yes No See Plans and Pricing See Plans and Pricing
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-003 Apr 23, 2021 RX Yes No 8,357,697 See Plans and Pricing See Plans and Pricing
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-002 Apr 24, 2020 RX Yes Yes 10,071,085 See Plans and Pricing Y See Plans and Pricing
Neurocrine INGREZZA valbenazine tosylate CAPSULE;ORAL 209241-001 Apr 11, 2017 RX Yes No 11,026,939 See Plans and Pricing Y See Plans and Pricing
Neurocrine ONGENTYS opicapone CAPSULE;ORAL 212489-002 Apr 24, 2020 RX Yes Yes 8,907,099 See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for Neurocrine Drugs

Country Patent Number Estimated Expiration
Colombia 2018004589 See Plans and Pricing
World Intellectual Property Organization (WIPO) 2017112857 See Plans and Pricing
South Korea 20090079257 See Plans and Pricing
Australia 2010231961 See Plans and Pricing
European Patent Office 2481410 See Plans and Pricing
China 101553487 See Plans and Pricing
Israel 200020 See Plans and Pricing
>Country >Patent Number >Estimated Expiration

Supplementary Protection Certificates for Neurocrine Drugs

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
1907382 16C1016 France See Plans and Pricing PRODUCT NAME: OPICAPONE OU UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLE; REGISTRATION NO/DATE: EU/1/15/1066 20160628
1907382 57/2016 Austria See Plans and Pricing PRODUCT NAME: OPICAPON ODER EIN PHARMAZEUTISCH ANNEHMBARES SALZ DAVON; REGISTRATION NO/DATE: EU/1/15/1066 (MITTEILUNG) 20160628
1907382 132016000123029 Italy See Plans and Pricing PRODUCT NAME: OPICAPONE O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE(ONGENTYS); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/15/1066, 20160628
1907382 PA2016036,C1907382 Lithuania See Plans and Pricing PRODUCT NAME: OPIKAPONAS ARBA JO FARMACINIU POZIURIU PRIIMTINOS DRUSKOS; REGISTRATION NO/DATE: EU/1/15/1066 20160624
1907382 C01907382/01 Switzerland See Plans and Pricing PRODUCT NAME: OPICAPON; REGISTRATION NO/DATE: SWISSMEDIC-ZULASSUNG 66547 26.04.2018
1907382 271 50011-2016 Slovakia See Plans and Pricing PRODUCT NAME: OPIKAPON VO VSETKYCH FORMACH CHRANENYCH ZA- KLADNYM PATENTOM; REGISTRATION NO/DATE: EU/1/15/1066/001 - EU/1/15/1066/010 20160628
1907382 CA 2016 00061 Denmark See Plans and Pricing PRODUCT NAME: OPICAPONE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/15/1066 20160628
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Johnson and Johnson
AstraZeneca
McKesson
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.